-
Cindy GUO
Equity Partner / Shanghai
-
Tel +86-21-6061-3584
Email guowen@zhonglun.com
-
Practices

Investment/M&A & Corporate Governance, Private Equity & Investment Funds, Hong Kong & Overseas Capital Markets
Cindy GUO
Cindy Guo specializes in cross-border M&A as well as investment and financing. She has long provided legal services to major multinational corporations in relation to their cross-border transactions. She has gained extensive experience in industries such as high-end manufacturing, biopharma, new materials, and new energy vehicles, and is particularly skilled in handling complex multi-jurisdictional M&A and restructuring transactions.
Since the beginning of her legal career, Cindy Guo has actively participated in major waves of foreign-related business, including foreign direct investment, cross-border M&A, and outbound investments of Chinese companies in the post-subprime crisis era. She has not only advised numerous Fortune 500 companies and multinational corporations on their investments in China but also represented large Chinese companies in multiple overseas investment projects. Through her extensive experience representing clients from compound roles and different jurisdictions, Cindy Guo has accurately developed deep insights and precise understanding into the commercial needs of clients. Cindy Guo excels at tailoring legal solutions that balance the interests of all parties, align with practical requirements and take into account the unique characteristics and regional attributes of different clients. Her professionalism and legal cultivation have earned her the lasting trust and recognition of her numerous clients.
In addition, Cindy Guo had been working as a seconded in-house counsel for 3M, where she was responsible for legal affairs related to their Chinese business in the healthcare and automotive industries.
Representative Matters
M&A and Corporate Restructuring
Advised Bausch Health's aesthetics business (a company listed on both NYSE and TSX), Solta Medical, on its successful acquisition of long-term distribution partner, Shibo Group
Advised the shareholders of Chengting Group, a renowned hearing aid retailer, on the sale of hearing aid retail business to Sonova, a Swiss listed company
Advised SIIC Capital on its strategic investment in MicroPort Scientific Corporation, a Hong Kong listed company
Advised Huyue Fund of SIICFM on its investment in the restructuring project of Tsinghua Unigroup
Advised ReLive, a tissue engineering and regenerative medicine company, on its acquisition of the German listed company co. don
Advised Mycronic AB, a Swedish listed company, on its acquisition of a controlling stake in Axxon, a leading company in SMT industry, establishment of a joint venture, and subsequent acquisition of the remaining equity
Advised Mycronic AB, a Swedish listed company, on its acquisition of a controlling stake in Huan Cheng Xin, a leading company in SMT industry, establishment of a joint venture, and subsequent acquisition of the remaining equity
Advised Mycronic AB, a Swedish listed company, on its acquisition of atg Group from Cohu, a Nasdaq-listed company
Advised ALS, an Australian listed company, on the sale of its domestic geological inspection business to CTI, a Chinese A-share listed company
Advised ALS, an Australian listed company, on its sale of environmental inspection business in China to Suez Group, a French listed company
Advised ALS UK on its acquisition of equity interests in a Mongolian inspection company held by its JV partner
Advised Shanying Intl, a Chinese A-share listed company, on its acquisition of a Swedish company, Nordic Paper
Advised IPCO AB, a global leading steel strip industrial process solutions company, on its acquisition of Longwin New Material
Advised two funds of JAC Capital on their strategic investment in a Korea company, Bee Semiconductor Technology
Advised for a Danish multinational water treatment company in the bidding process on its acquisition of a major water treatment equipment company under PRC law, including but not limited to issuing legal due diligence report, etc.
Advised a famous German fan equipment manufacturer on its sale of the business in China from the perspective of PRC law
Advised a multinational pharmaceutical company on completing the sale of the overall rights and interests in Greater China of a drug for defect repairing of cartilage
Advised New Value Fund, a domestic investment fund, on its acquisition of a well-known education company, EIC Education, from CVC
Advised Fullshare Holdings, a Hong Kong listed company, on its acquisition of multiple real estate projects
Advised GLP, a leading logistics real estate company, on its acquisition of various logistics properties
Advised Logos Property, a well-known Australian real estate fund, on its acquisition of logistics properties
Advised 3M, a US listed company, on its acquisition of a Chinese orthotics company
PE/VC and Other Investments
Advised AVATR, a high-end electric vehicle company, on its several-rounds financing
Advised Huming Fund of SIICFM on its investment in Unisoc
Advised China Life Investment Management Co. on additional investments in its two real estates (Aldgate Tower & 10 Upper Bank Street) in London
Advised Goldman Sachs on its investment in Burger King
Advised a leading fabric technology company on its establishment, Series Angel and Series A financing
Advised a client on its investment in a renowned general artificial intelligence technology company
Advised a Chinese chip company, GEO-CHIP, on its Series B+ round financing
Advised OCBC on its investment in C+ round financing of a Suzhou autonomous driving company, CalmCar
Advised a biopharmaceutical company specializing in defect repairing of cartilage on its Series Angel financing
Advised ReLive Biotechnologies, a tissue engineering and regenerative medicine enterprise, on its multiple rounds of financing
Advised a Hong Kong listed company on its investment in a new energy vehicle company
Advised Wanxiang Auto, a high-tech company, on its financing project
Advised the founders' team of a game company, Gamepoch, on its financing project
Advised a 4C purification technology team from Stanford on its financing project
Advised CDH on its investment in I-Mab, a leading innovative biotechnology company in China
Advised a renowned proteomics platform company on its financing project
Advised a Singapore fund on its investment in a Stanford medical device incubation team
Advised a medical group founders' team on its financing project
Advised a big data center on its financing project
Advised a US augmented reality technology company on its financing project
Advised a well-known fund on its investment in a Chinese futures company
Advised a Hong Kong listed company on its investment in a well-known domestic hotel group
Honors and Awards
For Individual
ALB China Client Choice, Asian Legal Business, 2025
Rising Stars 2022, China Business Law Journal, 2022
Next Generation Lawyers, Legal 500, 2017
Publications
Foreign Investment in Micro-Credit Companies in China, China Business Law Journal, April 2011
Related
-
Articles Related
A New Era for Foreign Investment in Cinemas
2021-02-18 -
Awards Related
Zhong Lun Partner Cindy Guo Earns Spot in 2025 ALB China Client Choice
Zhong Lun partner Cindy Guo was among the honorees.
2025-09-22
-
Bar Admissions/Professional Qualifications
PRC Bar, 2011
-
Education
LL.M., University College London, 2008
LL.B., Anhui University, 2007 -
Professional Experience
Partner, non-equity partner, and associate, Zhong Lun Law Firm , 2014 - 2019
Associate, Martin Hu & Partners, 2009 - 2014 -
Languages
Chinese
English